FDA Inspection 1326502 — Odin Pharmaceuticals, Inc.
The FDA completed an inspection of Odin Pharmaceuticals, Inc. on Jun 26, 2026 in Somerset, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 26, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Somerset, NJ (United States)
Additional Details
Bioanalytical BA/BE